Sign inJoin waitlistJoin the waitlist

MS

Melanie Smitt

Radiology / Radiation Oncology

Credentials: ·

Research

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
New England Journal of Medicine · 2019 · 2,052 citations
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2014 · 569 citations
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results…
The Lancet Oncology · 2017 · 438 citations

Don Goffinet
6 papers
IK
Ian Krop
5 papers
Robert Carlson
3 papers
Sarah Donaldson
3 papers
Alison Conlin
2 papers
Charles Geyer
2 papers
EM
Eleftherios Mamounas
2 papers
Irene Wapnir
2 papers
Michael DiGiovanna
2 papers
Norman Wolmark
2 papers
Patricia LoRusso
2 papers
Stefanie Jeffrey
2 papers